OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to the following deanol bitartrate (CAS RN 29870-28-8/ 5988-51-2), deanol acetamidobenzoate (CAS RN 3635-74-3), deanol benzilate hydrochloride (CAS RN 71-79-4), deanol hydrochloride (CAS RN 2498-25-1), deanol benzilate (CAS RN 968-46-7), deanol aceglutamate (CAS RN 3342-61-8), deanol bisorcate (CAS RN 84083-22-7), deanol orotate (CAS RN 1446-06-6), deanol glutamate (CAS RN 22199-70-8), deanol pidolate (CAS RN 23513-72-6), deanol phosphate (CAS RN 53562-95-1), deanol hemisuccinate (CAS RN Not Available), and deanol citrate (CAS RN Not Available). Deanol is commonly referred to as 2-(dimethylamino)ethanol, dimethylaminoethanol (DMAE) or dimethylethanolamine (DMEA). It holds tertiary amine and primary alcohol groups as functional groups. Deanol has been used in the treatment of attention deficit-hyperactivity disorder (ADHD), Alzheimer's disease, autism and tardive dyskinesia. Deanol has been also used as an ingredient in skin care, and in cognitive function- and mood-enhancing products.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Deanol, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.